BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 9046952)

  • 1. Paraneoplastic syndromes affecting the central nervous system.
    Posner JB; Dalmau JO
    Annu Rev Med; 1997; 48():157-66. PubMed ID: 9046952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmune paraneoplastic neurological syndromes].
    Lövblad KO; Steck AJ
    Schweiz Rundsch Med Prax; 1992 Nov; 81(48):1455-7. PubMed ID: 1448641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour therapy in paraneoplastic neurological disease.
    Grisold W; Drlicek M; Liszka-Setinek U; Wondrusch E
    Clin Neurol Neurosurg; 1995 Feb; 97(1):106-11. PubMed ID: 7788965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
    Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
    Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
    Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
    Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
    Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
    Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic neuromuscular syndromes.
    Levin KH
    Neurol Clin; 1997 Aug; 15(3):597-614. PubMed ID: 9227955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic syndromes: a review].
    Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
    Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic syndromes affecting the nervous system.
    Dalmau JO; Posner JB
    Semin Oncol; 1997 Jun; 24(3):318-28. PubMed ID: 9208887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lambert-Eaton syndrome].
    Osterhage J; Jost WH; Schimrigk K
    Med Klin (Munich); 1996 Aug; 91(8):526-30. PubMed ID: 8965753
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advance in immunological tests in paraneoplastic neurological syndrome.
    Fong CS
    Acta Neurol Taiwan; 2005 Mar; 14(1):28-35. PubMed ID: 15835287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system paraneoplastic disease.
    Rosenfeld MR; Dalmau J
    Handb Clin Neurol; 2012; 105():853-64. PubMed ID: 22230537
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis of central nervous system paraneoplastic syndromes.
    Posner JB
    Rev Neurol (Paris); 1992; 148(6-7):502-12. PubMed ID: 1280371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
    Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient.
    Kawahara M; Furuse K; Kodama N; Ogawara M; Kubota K; Yamamoto S; Tada H; Mori T; Miyawaki Y; Hirohashi S
    Jpn J Clin Oncol; 1994 Aug; 24(4):224-7. PubMed ID: 8072202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical enigmas of paraneoplastic neurologic disorders.
    Posner JB; Dalmau J
    Clin Neurol Neurosurg; 1995 Feb; 97(1):61-70. PubMed ID: 7788978
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.